牛牛AI助理已提取核心訊息
On December 31, 2023, a significant filing was made with the United States Securities and Exchange Commission (SEC) by Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz regarding their collective ownership in Tonix Pharmaceuticals Holding Corp. According to the Schedule 13G document, each of the reporting entities disclosed a shared voting and dispositive power over 5,205,348 shares of Tonix Pharmaceuticals' common stock, which represents 9.99% of the company's class of securities. The entities involved are Sabby Volatility Warrant Master Fund, Ltd., based in the Cayman Islands, Sabby Management, LLC, a Delaware limited liability company, and Hal Mintz, an individual from the USA. Sabby Management, LLC serves as the investment manager of Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz...Show More
On December 31, 2023, a significant filing was made with the United States Securities and Exchange Commission (SEC) by Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz regarding their collective ownership in Tonix Pharmaceuticals Holding Corp. According to the Schedule 13G document, each of the reporting entities disclosed a shared voting and dispositive power over 5,205,348 shares of Tonix Pharmaceuticals' common stock, which represents 9.99% of the company's class of securities. The entities involved are Sabby Volatility Warrant Master Fund, Ltd., based in the Cayman Islands, Sabby Management, LLC, a Delaware limited liability company, and Hal Mintz, an individual from the USA. Sabby Management, LLC serves as the investment manager of Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz is the manager of Sabby Management, LLC, which accounts for their indirect ownership of the shares. The filing, dated January 3, 2024, asserts that the shares were not acquired for the purpose of changing or influencing the control of Tonix Pharmaceuticals and were not part of a transaction with such a purpose or effect.
2023年12月31日，薩比波動率權證萬事達基金有限公司、Sabby Management, LLC和Hal Mintz就其在Tonix製藥控股公司的集體所有權向美國證券交易委員會（SEC）提交了一份重要文件。根據附表13G文件，每個申報實體都披露了對Tonix Pharmaceuticals普通股5,205,348股的共享投票權和處置權，佔9.99％ 公司的證券類別。涉及的實體包括總部位於開曼群島的Sabby波動率權證萬事達基金有限公司、特拉華州有限責任公司Sabby Management, LLC和來自美國的個人Hal Mintz。Sabby Management, LLC擔任Sabby波...展開全部
2023年12月31日，薩比波動率權證萬事達基金有限公司、Sabby Management, LLC和Hal Mintz就其在Tonix製藥控股公司的集體所有權向美國證券交易委員會（SEC）提交了一份重要文件。根據附表13G文件，每個申報實體都披露了對Tonix Pharmaceuticals普通股5,205,348股的共享投票權和處置權，佔9.99％ 公司的證券類別。涉及的實體包括總部位於開曼群島的Sabby波動率權證萬事達基金有限公司、特拉華州有限責任公司Sabby Management, LLC和來自美國的個人Hal Mintz。Sabby Management, LLC擔任Sabby波動率權證萬事達基金有限公司的投資經理，哈爾·明茨是Sabby Management, LLC的經理，該公司說明了他們對股票的間接所有權。這份日期爲2024年1月3日的文件稱，收購這些股票不是爲了改變或影響Tonix Pharmicals的控制權，也不是具有這種目的或效果的交易的一部分。
有用
沒用